Indaptus Therapeutics, Inc.
INDP
$0.4649
-$0.0151-3.15%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 5.79M | 7.38M | 7.30M | 9.74M | 13.36M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 681.60K | 236.60K | 180.40K | 436.30K | 615.80K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 150.00K | 12.10K | 6.30K | 114.70K | 17.30K |
Total Current Assets | 6.62M | 7.63M | 7.49M | 10.29M | 14.00M |
|
|||||
Total Current Assets | 6.62M | 7.63M | 7.49M | 10.29M | 14.00M |
Net Property, Plant & Equipment | 82.20K | 105.70K | 128.60K | 151.10K | 173.90K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 638.30K | 504.70K | 504.70K | 504.70K | 754.70K |
Total Assets | 7.34M | 8.24M | 8.12M | 10.95M | 14.92M |
|
|||||
Total Accounts Payable | 870.20K | 555.90K | 416.60K | 405.50K | 806.00K |
Total Accrued Expenses | 2.44M | 1.57M | 1.41M | 1.03M | 1.87M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 84.20K | 104.00K | 103.20K | 102.50K | 101.70K |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 3.39M | 2.23M | 1.93M | 1.54M | 2.77M |
|
|||||
Total Current Liabilities | 3.39M | 2.23M | 1.93M | 1.54M | 2.77M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | 4.00K | 27.60K | 50.70K | 73.30K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 3.39M | 2.24M | 1.96M | 1.59M | 2.85M |
|
|||||
Common Stock & APIC | 64.38M | 62.31M | 59.41M | 58.58M | 57.49M |
Retained Earnings | -60.44M | -56.31M | -53.24M | -49.22M | -45.42M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 3.94M | 6.00M | 6.17M | 9.36M | 12.08M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 3.94M | 6.00M | 6.17M | 9.36M | 12.08M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 3.94M | 6.00M | 6.17M | 9.36M | 12.08M |
|